Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics
Cancer is a disease that undergoes selective pressure to evolve during its progression, becoming increasingly heterogeneous. Tumoral heterogeneity can dictate therapeutic response. Transcriptomics can be used to uncover complexities in cancer and reveal phenotypic heterogeneity that affects disease...
| Main Authors: | , , , , , , |
|---|---|
| 其他作者: | |
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Springer Netherlands
2023
|
| 在线阅读: | https://hdl.handle.net/1721.1/153162 |
| _version_ | 1826189076715274240 |
|---|---|
| author | Liu, Wendi Puri, Anusha Fu, Doris Chen, Lee Wang, Cassia Kellis, Manolis Yang, Jiekun |
| author2 | Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory |
| author_facet | Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory Liu, Wendi Puri, Anusha Fu, Doris Chen, Lee Wang, Cassia Kellis, Manolis Yang, Jiekun |
| author_sort | Liu, Wendi |
| collection | MIT |
| description | Cancer is a disease that undergoes selective pressure to evolve during its progression, becoming increasingly heterogeneous. Tumoral heterogeneity can dictate therapeutic response. Transcriptomics can be used to uncover complexities in cancer and reveal phenotypic heterogeneity that affects disease response. This is especially pertinent in the immune microenvironment, which contains diverse populations of immune cells, and whose dynamic properties influence disease response. The recent development of immunotherapies has revolutionized cancer therapy, with response rates of up to 50% within certain cancers. However, despite advances in immune checkpoint blockade specifically, there remains a significant population of non-responders to these treatments. Transcriptomics can be used to profile immune and other cell populations following immune-checkpoint inhibitor (ICI) treatment, generate predictive biomarkers of resistance or response, assess immune effector function, and identify potential immune checkpoints. Single-cell RNA sequencing has offered insight into mRNA expression within the complex and heterogeneous tumor microenvironment at single-cell resolution. Spatial transcriptomics has enabled measurement of mRNA expression while adding locational context. Here, we review single-cell sequencing and spatial transcriptomic research investigating ICI response within a variety of cancer microenvironments. |
| first_indexed | 2024-09-23T08:09:10Z |
| format | Article |
| id | mit-1721.1/153162 |
| institution | Massachusetts Institute of Technology |
| language | English |
| last_indexed | 2024-09-23T08:09:10Z |
| publishDate | 2023 |
| publisher | Springer Netherlands |
| record_format | dspace |
| spelling | mit-1721.1/1531622024-01-24T21:50:19Z Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics Liu, Wendi Puri, Anusha Fu, Doris Chen, Lee Wang, Cassia Kellis, Manolis Yang, Jiekun Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory Massachusetts Institute of Technology. Department of Biological Engineering Cancer is a disease that undergoes selective pressure to evolve during its progression, becoming increasingly heterogeneous. Tumoral heterogeneity can dictate therapeutic response. Transcriptomics can be used to uncover complexities in cancer and reveal phenotypic heterogeneity that affects disease response. This is especially pertinent in the immune microenvironment, which contains diverse populations of immune cells, and whose dynamic properties influence disease response. The recent development of immunotherapies has revolutionized cancer therapy, with response rates of up to 50% within certain cancers. However, despite advances in immune checkpoint blockade specifically, there remains a significant population of non-responders to these treatments. Transcriptomics can be used to profile immune and other cell populations following immune-checkpoint inhibitor (ICI) treatment, generate predictive biomarkers of resistance or response, assess immune effector function, and identify potential immune checkpoints. Single-cell RNA sequencing has offered insight into mRNA expression within the complex and heterogeneous tumor microenvironment at single-cell resolution. Spatial transcriptomics has enabled measurement of mRNA expression while adding locational context. Here, we review single-cell sequencing and spatial transcriptomic research investigating ICI response within a variety of cancer microenvironments. 2023-12-14T16:27:23Z 2023-12-14T16:27:23Z 2023-12-08 2023-12-10T04:07:32Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/153162 Liu, Wendi, Puri, Anusha, Fu, Doris, Chen, Lee, Wang, Cassia et al. 2023. "Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics." PUBLISHER_CC en https://doi.org/10.1007/s10585-023-10246-2 Creative Commons Attribution https://creativecommons.org/licenses/by/4.0/ The Author(s) application/pdf Springer Netherlands Springer Netherlands |
| spellingShingle | Liu, Wendi Puri, Anusha Fu, Doris Chen, Lee Wang, Cassia Kellis, Manolis Yang, Jiekun Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics |
| title | Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics |
| title_full | Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics |
| title_fullStr | Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics |
| title_full_unstemmed | Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics |
| title_short | Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics |
| title_sort | dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single cell and spatial transcriptomics |
| url | https://hdl.handle.net/1721.1/153162 |
| work_keys_str_mv | AT liuwendi dissectingthetumormicroenvironmentinresponsetoimmunecheckpointinhibitorsviasinglecellandspatialtranscriptomics AT purianusha dissectingthetumormicroenvironmentinresponsetoimmunecheckpointinhibitorsviasinglecellandspatialtranscriptomics AT fudoris dissectingthetumormicroenvironmentinresponsetoimmunecheckpointinhibitorsviasinglecellandspatialtranscriptomics AT chenlee dissectingthetumormicroenvironmentinresponsetoimmunecheckpointinhibitorsviasinglecellandspatialtranscriptomics AT wangcassia dissectingthetumormicroenvironmentinresponsetoimmunecheckpointinhibitorsviasinglecellandspatialtranscriptomics AT kellismanolis dissectingthetumormicroenvironmentinresponsetoimmunecheckpointinhibitorsviasinglecellandspatialtranscriptomics AT yangjiekun dissectingthetumormicroenvironmentinresponsetoimmunecheckpointinhibitorsviasinglecellandspatialtranscriptomics |